New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the...
Shortened Exclusivity Could Save $31B Alex Brill was recently quoted by Politico Pro about MGA’s recent “Gamesmanship and Other Barriers to Drug Competition” paper: “Brand-name medicines’ market exclusivity periods have climbed an average...
